Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliance PharmafiledCriticalAlliance Pharma
Publication of MX9709697ApublicationCriticalpatent/MX9709697A/en
Publication of MXPA97009697ApublicationCriticalpatent/MXPA97009697A/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
A method for hemodiluting a patient is disclosed which includes the steps of administering a biocompatible oxygen carrier in conjunction with surgery or organ ischemia or infarct while assessing the patient's PvO2 or other oxygenation indices, and administering to the patient additional oxygen carrier or autologous blood in response to the PvO2 value if necessary to maintain the PvO2 at or above the desired level.
MXPA/A/1997/009697A1995-06-071997-12-05Hemodulation facilitated by the monitoring of the condition of oxigenac
MXPA97009697A
(en)